82448-260 : Gomekli 2 mg Oral Capsule
| NDC: | 82448-260 |
| Labeler: | Springworks Therapeutics, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Gomekli |
| Dosage Form: | Oral Capsule |
| Application #: | NDA219389 |
| Rev. Date: |
NDC Package Codes:
- 82448-260-42: 42 CAPSULE IN 1 BOTTLE (82448‑260‑42)
- 82448-260-84: 84 CAPSULE IN 1 BOTTLE (82448‑260‑84)
Active Ingredients:
- Mirdametinib
Dosage Strength:
- 2 mg
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]
- Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 82448-130 Gomekli 1 mg Oral Capsule by Springworks Therapeutics, Inc.
- 82448-134 Gomekli 1 mg Oral Tablet, for Suspension by Springworks Therapeutics, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 82448-150Next: 82449-000 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.